SCHEMBL4882489

SCHEMBL4882489

O=C(Nc1ccc(C2[C@H]3CSC[C@@H]23)cc1)OCc1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 7/20 0.62
MAOA P21397 4/20 0.62
MAOB P27338 2/20 0.62
RCOR1 Q9UKL0 5/20 0.61
POLB P06746 1/20 0.54
TP53 P04637 2/20 0.51
MAPT P10636 2/20 0.51
KDM1B Q8NB78 2/20 0.50
NPC1 O15118 1/20 0.50
ALDH1A1 P00352 1/20 0.50
TSHR P16473 1/20 0.50
RAB9A P51151 1/20 0.50
ATM Q13315 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
ROCK2 O75116 1/20 0.49
MGLL Q99685 1/20 0.49
HRH3 Q9Y5N1 2/20 0.48
TGM2 P21980 1/20 0.47
PDE3B Q13370 1/20 0.47
PDE3A Q14432 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14197156 1.00 KDM1A (0.62) KDM1AMAOAMAOBRCOR1POLB
SCHEMBL4879581 0.85 KDM1A (0.62) KDM1AMAOAMAOBRCOR1POLB
SCHEMBL14197144 0.85 KDM1A (0.62) KDM1AMAOAMAOBRCOR1POLB
SCHEMBL5369903 0.82 MGLL (0.49) KDM1AMAOAMAOBRCOR1POLB
SCHEMBL14370633 0.82 MGLL (0.49) KDM1AMAOAMAOBRCOR1POLB
SCHEMBL4879529 0.82 MGLL (0.52) KDM1AMAOAMAOBRCOR1POLB
SCHEMBL14197109 0.82 MGLL (0.52) KDM1AMAOAMAOBRCOR1POLB
SCHEMBL14197147 0.81 KDM1A (0.63) KDM1AMAOAMAOBRCOR1POLB
SCHEMBL4879227 0.81 KDM1A (0.63) KDM1AMAOAMAOBRCOR1POLB
SCHEMBL4882601 0.79 KDM1A (0.58) KDM1AMAOAMAOBRCOR1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090884-A1 ANTIMICROBIAL [3.1.0] BICYCLOHEXYLPHENYL- OXAZOLIDINONE DERIVATIVES AND ANALOGUES PFIZER INC 2008-04-17 US disclosed
US-7279494-B2 Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues PFIZER INC. (US) 2007-10-09 US disclosed
US-20050192325-A1 Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues RENSLO ADAM (US) 2005-09-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050192325-A1 Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues OXA1L, CYP51A1, CYP2C19 KDM1A 3017/4885MAOA 1957/4885MAOB 1797/4885
US-20080090884-A1 ANTIMICROBIAL [3.1.0] BICYCLOHEXYLPHENYL- OXAZOLIDINONE DERIVATIVES AND ANALOGUES OXA1L, CYP51A1, CYP2C19 KDM1A 2836/4885MAOA 1931/4885MAOB 1736/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.